Literature DB >> 3918914

Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease.

A Raedler, S Fraenkel, G Klose, K Seyfarth, H G Thiele.   

Abstract

Peripheral lymphocyte cells from patients suffering from Crohn's disease were analyzed for the expression of the "activation" antigens T9 and HLA-DR on their cell surface. It was found that high numbers of "activated" lymphocytes, the majority of which have proven to be T cells, could be detected in patients with active Crohn's disease, whereas in healthy controls and inactive disease only a small subfraction of lymphocytes was positive for these antigens. This difference was highly significant (p = 0.0001). Within the subpopulation of T9-positive cells the ratio between T4- and T8-positive cells is about 1.8 (compared with 2.0 in the total T-cell subset). All HLA-DR-positive, non-B and non-glass-adherent cells could be detected in the T9-positive cell fraction. The presence of T9 antigens was found to correlate with the grade of severity of the disease as assessed by a Crohn's disease activity index. The presence of high amounts of T cells exhibiting this antigen is not restricted to Crohn's disease but is thought to be of importance as a marker for the involvement of the immune system in other maladies as well. Nevertheless, the determination of T9 antigen is expected to provide objective data reflecting the severity of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918914     DOI: 10.1016/s0016-5085(85)80017-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.

Authors:  G A Neil; R W Summers; B A Cheyne; C Capenter; W L Huang; G S Kansas; T J Waldschmidt
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

2.  Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.

Authors:  J E Crabtree; L D Juby; R V Heatley; A J Lobo; D W Bullimore; A T Axon
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

3.  Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease.

Authors:  Y R Mahida; A Gallagher; L Kurlak; C J Hawkey
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

4.  Interferon-alpha (IFN-alpha) production by human intestinal mononuclear cells. Response to virus in control subjects and in Crohn's disease.

Authors:  M R Capobianchi; S Fais; F Mercuri; M Boirivant; F Dianzani; F Pallone
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

5.  Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse.

Authors:  E Louis; J Belaiche; C Van Kemseke; N Schaaf; P Mahieu; J Y Mary
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

6.  Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD).

Authors:  R Giacomelli; A Passacantando; I Parzanese; P Vernia; N Klidara; F Cucinelli; R Lattanzio; E Santori; P Cipriani; R Caprilli; G Tonietti
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

7.  Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.

Authors:  F Pallone; S Fais; O Squarcia; L Biancone; P Pozzilli; M Boirivant
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

8.  Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease.

Authors:  S Schreiber; A Raedler; A R Conn; J L Rombeau; R P MacDermott
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

9.  Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease.

Authors:  B R Yacyshyn; L M Pilarski
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

10.  Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease.

Authors:  B Gulwani-Akolkar; P N Akolkar; A Minassian; R Pergolizzi; M McKinley; G Mullin; S Fisher; J Silver
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.